Ketamine Associated ACC GABA and Glutamate Change and Depression Remission:

Clinical trial NCT03573349 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03573349
Sponsor: Mayo Clinic
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Major Depressive Disorder Treatment Resistant Depression Bipolar Depression

Start date: 2019-01-03
Primary completion: 2026-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.